Does the media refer more to HIMS or GH?

In the previous week, Hims & Hers Health had 27 more articles in the media than Guardant Health. MarketBeat recorded 39 mentions for Hims & Hers Health and 12 mentions for Guardant Health. Guardant Health's average media sentiment score of 1.35 beat Hims & Hers Health's score of 0.27 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 12 Very Positive mention(s) 3 Positive mention(s) 15 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Guardant Health 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BTSG or HIMS?

In the previous week, Hims & Hers Health had 33 more articles in the media than BrightSpring Health Services. MarketBeat recorded 39 mentions for Hims & Hers Health and 6 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.41 beat Hims & Hers Health's score of 0.27 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 12 Very Positive mention(s) 3 Positive mention(s) 15 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, DVA or HIMS?

DaVita has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DaVita $13.64B 0.81 $746.80M $12.22 14.26 Hims & Hers Health $2.35B 3.35 $128.37M -$0.63 N/A

Is DVA or HIMS more profitable?

DaVita has a net margin of 6.05% compared to Hims & Hers Health's net margin of -5.51%. Hims & Hers Health's return on equity of -6.51% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets DaVita 6.05% -217.63% 5.07% Hims & Hers Health -5.51% -6.51% -1.20%

Does the media prefer DVA or HIMS?

In the previous week, Hims & Hers Health had 35 more articles in the media than DaVita. MarketBeat recorded 39 mentions for Hims & Hers Health and 4 mentions for DaVita. DaVita's average media sentiment score of 1.74 beat Hims & Hers Health's score of 0.27 indicating that DaVita is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Hims & Hers Health 12 Very Positive mention(s) 3 Positive mention(s) 15 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to TEM or HIMS?

In the previous week, Hims & Hers Health had 6 more articles in the media than Tempus AI. MarketBeat recorded 39 mentions for Hims & Hers Health and 33 mentions for Tempus AI. Tempus AI's average media sentiment score of 0.55 beat Hims & Hers Health's score of 0.27 indicating that Tempus AI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 18 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 12 Very Positive mention(s) 3 Positive mention(s) 15 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Hims & Hers Health (HIMS) Competitors

$33.67 +1.81 (+5.68%)

As of 08/21/2026 03:58 PM Eastern

Compare

HIMS vs. GH, FMS, BTSG, DVA, and TEM

Should you buy Hims & Hers Health stock or one of its competitors? Hims & Hers Health's main competitors and comparable companies include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), DaVita (DVA), and Tempus AI (TEM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Hims & Hers Health compare to Guardant Health?

Hims & Hers Health (NYSE:HIMS) and Guardant Health (NASDAQ:GH) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability.

Hims & Hers Health has higher revenue and earnings than Guardant Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.35	$128.37M	-$0.63	N/A
Guardant Health	$982.02M	23.33	-$416.28M	-$3.49	N/A

Hims & Hers Health has a beta of 2.4, meaning that its share price is 140% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market.

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 5.6% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Hims & Hers Health currently has a consensus target price of $32.17, suggesting a potential downside of 4.46%. Guardant Health has a consensus target price of $183.78, suggesting a potential upside of 7.67%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts plainly believe Guardant Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96

In the previous week, Hims & Hers Health had 27 more articles in the media than Guardant Health. MarketBeat recorded 39 mentions for Hims & Hers Health and 12 mentions for Guardant Health. Guardant Health's average media sentiment score of 1.35 beat Hims & Hers Health's score of 0.27 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	12 Very Positive mention(s)	3 Positive mention(s)	15 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has a net margin of -5.51% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Guardant Health	-38.33%	N/A	-25.40%

Summary

Guardant Health beats Hims & Hers Health on 9 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Hims & Hers Health (NYSE:HIMS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

Hims & Hers Health currently has a consensus target price of $32.17, suggesting a potential downside of 4.46%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.57, suggesting a potential upside of 0.58%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Hims & Hers Health had 37 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 39 mentions for Hims & Hers Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.27 beat Hims & Hers Health's score of 0.27 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	12 Very Positive mention(s)	3 Positive mention(s)	15 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has a beta of 2.4, meaning that its stock price is 140% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.35	$128.37M	-$0.63	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.57	$1.11B	$1.93	12.14

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Hims & Hers Health's net margin of -5.51%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

Summary

Fresenius Medical Care AG & Co. KGaA beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

BrightSpring Health Services presently has a consensus target price of $70.71, indicating a potential upside of 20.11%. Hims & Hers Health has a consensus target price of $32.17, indicating a potential downside of 4.46%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts clearly believe BrightSpring Health Services is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

BrightSpring Health Services has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	0.90	$190.67M	$1.66	35.46
Hims & Hers Health	$2.35B	3.35	$128.37M	-$0.63	N/A

In the previous week, Hims & Hers Health had 33 more articles in the media than BrightSpring Health Services. MarketBeat recorded 39 mentions for Hims & Hers Health and 6 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.41 beat Hims & Hers Health's score of 0.27 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	12 Very Positive mention(s)	3 Positive mention(s)	15 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

63.5% of Hims & Hers Health shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

BrightSpring Health Services has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, meaning that its stock price is 140% more volatile than the broader market.

BrightSpring Health Services has a net margin of 2.55% compared to Hims & Hers Health's net margin of -5.51%. BrightSpring Health Services' return on equity of 16.73% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.55%	16.73%	5.24%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Summary

BrightSpring Health Services beats Hims & Hers Health on 12 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to DaVita?

DaVita (NYSE:DVA) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

DaVita currently has a consensus price target of $221.75, suggesting a potential upside of 27.29%. Hims & Hers Health has a consensus price target of $32.17, suggesting a potential downside of 4.46%. Given DaVita's stronger consensus rating and higher probable upside, analysts clearly believe DaVita is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

DaVita has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$13.64B	0.81	$746.80M	$12.22	14.26
Hims & Hers Health	$2.35B	3.35	$128.37M	-$0.63	N/A

DaVita has a net margin of 6.05% compared to Hims & Hers Health's net margin of -5.51%. Hims & Hers Health's return on equity of -6.51% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	6.05%	-217.63%	5.07%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

DaVita has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, meaning that its stock price is 140% more volatile than the broader market.

90.1% of DaVita shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 1.9% of DaVita shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Hims & Hers Health had 35 more articles in the media than DaVita. MarketBeat recorded 39 mentions for Hims & Hers Health and 4 mentions for DaVita. DaVita's average media sentiment score of 1.74 beat Hims & Hers Health's score of 0.27 indicating that DaVita is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Hims & Hers Health	12 Very Positive mention(s)	3 Positive mention(s)	15 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

DaVita beats Hims & Hers Health on 10 of the 15 factors compared between the two stocks.

How does Hims & Hers Health compare to Tempus AI?

Tempus AI (NASDAQ:TEM) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

In the previous week, Hims & Hers Health had 6 more articles in the media than Tempus AI. MarketBeat recorded 39 mentions for Hims & Hers Health and 33 mentions for Tempus AI. Tempus AI's average media sentiment score of 0.55 beat Hims & Hers Health's score of 0.27 indicating that Tempus AI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	18 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	12 Very Positive mention(s)	3 Positive mention(s)	15 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Tempus AI currently has a consensus target price of $65.69, indicating a potential downside of 9.63%. Hims & Hers Health has a consensus target price of $32.17, indicating a potential downside of 4.46%. Given Hims & Hers Health's higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

Hims & Hers Health has higher revenue and earnings than Tempus AI. Hims & Hers Health is trading at a lower price-to-earnings ratio than Tempus AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.43B	9.16	-$245.03M	-$1.44	N/A
Hims & Hers Health	$2.35B	3.35	$128.37M	-$0.63	N/A

24.2% of Tempus AI shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 24.3% of Tempus AI shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Tempus AI has a beta of 3.58, suggesting that its share price is 258% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, suggesting that its share price is 140% more volatile than the broader market.

Hims & Hers Health has a net margin of -5.51% compared to Tempus AI's net margin of -17.77%. Hims & Hers Health's return on equity of -6.51% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Summary

Hims & Hers Health beats Tempus AI on 9 of the 16 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIMS vs. The Competition

Export

Metric	Hims & Hers Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$7.43B	$9.71B	$7.27B	$24.12B
Dividend Yield	N/A	2.55%	2.54%	3.71%
P/E Ratio	-53.44	34.38	270.69	30.15
Price / Sales	3.35	5.03	639.89	24.31
Price / Cash	38.07	124.12	76.89	32.42
Price / Book	24.22	4.05	13.43	6.77
Net Income	$128.37M	$311.06M	$3.46B	$1.07B
7 Day Performance	19.60%	0.83%	2.15%	-0.62%
1 Month Performance	6.24%	1.29%	6.18%	2.47%
1 Year Performance	-24.39%	15.68%	24.96%	14.88%

Hims & Hers Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIMS Hims & Hers Health	1.8526 of 5 stars	$33.67 +5.7%	$32.17 -4.5%	-23.1%	$7.43B	$2.35B	N/A	2,442	Trending News Analyst Forecast Insider Trade
GH Guardant Health	2.6059 of 5 stars	$160.16 -0.9%	$183.78 +14.8%	+178.5%	$21.48B	$1.18B	N/A	2,506	Positive News
FMS Fresenius Medical Care AG & Co. KGaA	3.1651 of 5 stars	$23.59 +0.4%	$23.57 -0.1%	-7.1%	$12.67B	$22.20B	12.23	1,488	Positive News
BTSG BrightSpring Health Services	4.9738 of 5 stars	$59.50 -1.5%	$70.71 +18.8%	+145.7%	$11.77B	$12.91B	35.83	23,500	Positive News
DVA DaVita	4.8495 of 5 stars	$178.09 +0.8%	$221.75 +24.5%	+26.6%	$11.36B	$14.01B	14.57	78,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HIMS) was last updated on 8/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hims & Hers Health (HIMS) Competitors

HIMS vs. GH, FMS, BTSG, DVA, and TEM

How does Hims & Hers Health compare to Guardant Health?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Summary

How does Hims & Hers Health compare to DaVita?

Summary

How does Hims & Hers Health compare to Tempus AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hims & Hers Health (HIMS) Competitors

HIMS vs. GH, FMS, BTSG, DVA, and TEM

How does Hims & Hers Health compare to Guardant Health?

Which has better valuation and earnings, HIMS or GH?

Which has more volatility & risk, HIMS or GH?

Do institutionals and insiders have more ownership in HIMS or GH?

Do analysts recommend HIMS or GH?

Does the media refer more to HIMS or GH?

Is HIMS or GH more profitable?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Do analysts recommend HIMS or FMS?

Do insiders and institutionals hold more shares of HIMS or FMS?

Does the media favor HIMS or FMS?

Which has more volatility and risk, HIMS or FMS?

Which has better earnings & valuation, HIMS or FMS?

Is HIMS or FMS more profitable?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Do analysts rate BTSG or HIMS?

Which has higher valuation and earnings, BTSG or HIMS?

Does the media prefer BTSG or HIMS?

Do insiders & institutionals hold more shares of BTSG or HIMS?

Which has more risk and volatility, BTSG or HIMS?

Is BTSG or HIMS more profitable?

Summary

How does Hims & Hers Health compare to DaVita?

Do analysts rate DVA or HIMS?

Which has stronger valuation & earnings, DVA or HIMS?

Is DVA or HIMS more profitable?

Which has more volatility and risk, DVA or HIMS?

Do institutionals and insiders hold more shares of DVA or HIMS?

Does the media prefer DVA or HIMS?

Summary

How does Hims & Hers Health compare to Tempus AI?

Does the media refer more to TEM or HIMS?

Do analysts recommend TEM or HIMS?

Which has stronger earnings & valuation, TEM or HIMS?

Do institutionals and insiders believe in TEM or HIMS?

Which has more risk and volatility, TEM or HIMS?

Is TEM or HIMS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools